Vanguard (VXUS) vs. iShares (EEM): Which ETF Is Better For Investing in Stocks Outside the U.S.?

The key second-order issue is that EEM is not really a broad emerging-markets beta product anymore; it is increasingly a concentrated wager on a handful of Asian mega-cap tech proxies with embedded geopolitical and supply-chain risk. That concentration means the fund can look like an EM winner in risk-on bursts, but it will underperform badly when Taiwan/Korea risk premia widen or when semiconductor cycles roll over.

VXUS is the cleaner portfolio construction tool because it dilutes single-country and single-sector risk while still keeping EM upside exposure. The market is effectively paying a much lower fee for better diversification and a higher cash yield, which matters in a regime where real rates remain restrictive and investors are more sensitive to carry than to pure multiple expansion.

The recent 1-year outperformance of EEM may be less a durable signal than a cyclical beta snapback driven by AI/semis and dollar sensitivity. If that is right, the next leg is likely to be path-dependent: EEM can keep running only if TSM/ASML-led earnings revisions stay intact and geopolitical headlines remain benign. Any setback in Taiwan or a pause in semiconductor capex would likely hit EEM harder than VXUS over a 1-6 month horizon.

Consensus seems to be underestimating how much of EEM’s headline diversification is offset by hidden concentration in the same names investors already own through global tech portfolios. That creates crowding risk: EM allocators may think they are diversifying away from US tech, but they are often just adding a more volatile wrapper around the same semiconductor complex.